Labor Analgesia
Conditions
Interventions
Group CSE1 :Administration of 1 mg ropivacaine via intrathecal injection into the subarachnoid space.
Group CSE3 :Administration of 3 mg ropivacaine via intrathecal injection into the subarachnoid space.
Group DPE:No pharmacological agent was administered into the subarachnoid space following dural puncture.
Group EA:To meet the analgesic requirements, epidural administration alone was employed.
Sponsors
Women and Children’s Hospital of Ningbo University
Eligibility
Sex/Gender
Female
Age
25 Years to 40 Years
Inclusion criteria
Inclusion criteria: Primiparous women who were scheduled to undergo neuraxial delivery analgesia at the Women's Hospital Affiliated to Ningbo University from October 2025 to December 2025 were selected with a singleton pregnancy of 38 to 42 weeks, in active labor, and a cervical dilation < 5.0 cm.
Exclusion criteria
Exclusion criteria: Those with pregnancy diseases (such as gestational hypertension, preeclampsia or gestational diabetes), contraindications to neuraxial anesthesia, known fetal malformations or diseases associated with an increased risk of caesarean section (such as vaginal delivery after caesarean section, history of uterine rupture), etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Arrive at adequate analgesia time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Asymmetric blocks;Motor blocks;Adverse effects; | — |
Countries
China
Contacts
Public ContactLijun Yin
Women and Children’s Hospital of Ningbo University
Outcome results
None listed